1. Home
  2. Analysis
  3. Fempatch

Fempatch side effects, by duration, gender and age (a phase IV clinical study of FDA data)

Summary:

Side effects are reported by people who take Fempatch (estradiol). Common side effects include aphasia among females.

The phase IV clinical study is created by eHealthMe based on 15 reports from the FDA, and is updated regularly.

What is Fempatch?

Fempatch has active ingredients of estradiol. eHealthMe is studying from 17 Fempatch users. Check the latest studies of Fempatch.

On Mar, 27, 2026

15 people who take Fempatch and have side effects are studied.

Fempatch side effects.

What are the common side effects of Fempatch, by gender? *:

female:

  1. Aphasia (damage to the parts of the brain that control language)
  2. Ovarian cancer (cancer of ovary)
  3. Alanine aminotransferase increased
  4. Aldolase increased
  5. Breast cancer
  6. Breast cancer female
  7. Eye pain
  8. Skin irritation

male:

n/a

What are the common side effects of Fempatch, by age (0-1 to 60+) *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Alanine aminotransferase increased
  2. Aldolase increased
  3. Breast cancer
  4. Breast cancer female
  5. Eye pain

60+:

  1. Skin irritation

* Approximation only. Some reports may have incomplete information.

Do you take Fempatch?

- Personalize this study to your gender and age
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

How the study uses the data?

The study is based on estradiol (the active ingredients of Fempatch) and Fempatch (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies are listed below in case you need more information:

Alternative drugs to, pros and cons of Fempatch:

All Fempatch side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.